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ments for all four time points. Each one of the ﬁve repeated
measurement were then summarized with the trimmed average
(Average of the three middle measurements). The trimmed aver-
age measurements were used to compute the standardized femur
curvature, the standardized minimum contrast, and the standard-
ized minimum of medial and lateral tibia-to-femur bone distance.
Those measurements were used as surrogated measurements
for bone shape, tissue inﬂammation and unloaded tibia-femoral
join distance. Those measurements then were used to compute a
tree variable linear composite metric associated to the OA grade
(biomarker00 data set) and to the total WOMAC score of the right
knee (Joint0x data set). The weights of the linear combination of
three variables were selected in such a way to provide a strong
association to the total WOMAC score and the OA Grade score.
The qMRI composite index then was evaluated for responsiveness
to time using a linear model.
Results: From 196 subjects included in data release 3.C.1, only
179 subjects had the complete set of four time points with full
MRI quantiﬁcation. The computed qMRI composite index was
associated to total WOMAC (r=0.33, t=4.6, p<0.001) and to the
OAgrade scores (Spearman rho=0.51, p<0.001).
The coefﬁcients of the linear model are shown in Table 1. The
linear model of the responsiveness of the qMRI composite index
reduced the longitudinal variability of the index in 12%. (r2=0.116,
p<0.001). The index had an average annualized SRM of 0.14 for
the 179 subjects.
Table 1. Responsiveness to time: qMRIIndex – BLqMRIIndex = BLqMRIIndex ×
Time + Time
Coefﬁcients: Value Std.Error t-value p-value
Time 0.5054 0.0819 6.17455 0.00000000
BLqMRIIndex:Time -0.121 0.0219 -5.518 0.00000000
Conclusions: The image-analysis methodology and biomarker
discovery approach presented in this work was able to automat-
ically segment the OAI DESS images and used to provide an
objective index of the OA stage that is associated to the WOMAC
scores and to the OA grade scores. Furthermore, this index has
the potential to be used for automated objective screening for OA
progressors. The methodology has still to be validated using more
time points. It effectiveness and usefulness has still to be tested
in independent OA study cohorts.
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Purpose: To analyze the inﬂuence of mitochondrial DNA (mtDNA)
haplogroups on serum levels of molecular biomarkers in patients
with osteoarthritis (OA).
Methods: We analyzed serum levels of molecular biomarkers of
cartilage metabolism (collagen type II markers: Coll2-1, Coll2-
1NO2, C2C, CPII), synovial metabolism (hyaluronic acid (HA))
and cartilage and synovial turnover (YKL-40) in 73 OA cases
and 77 healthy controls using enzyme-linked immunosorbent as-
says (ELISAs). All subjects had been previously genotyped for the
mtDNA haplogroups J, U, and H. Non-parametric and multivariate
analysis were performed to test the effects of the clinical vari-
ables, including gender, age, smoking status, diagnosis, mtDNA
haplogroups and radiologic Kellgren/Lawrence (K/L) grade on the
serum levels of the molecular markers.
Results: Non parametric analysis showed increased serum levels
of HA in patients with OA, meanwhile the values for Coll2-1, C2C
and C2C/CPII ratio appeared statistically increased in healthy
controls. Multivariate analysis showed a clear incidence of the
mtDNA haplogroups in the serum levels of the typical type II
collagen markers. Carriers of the mtDNA haplogroup H had higher
levels and carriers of the mtDNA haplogroup J showed lower
levels. Statistical interactions between mtDNA haplogroups and
both diagnosis and radiologic K/L grade in the serum levels of the
molecular markers were also detected.
Conclusions: A new role for mtDNA haplogroups emerges from
this work. Our results suggest that the mtDNA haplogroups sig-
niﬁcantly interact with the serum levels of OA-related molecular
markers, suggesting the possibility of their use as a complemen-
tary assay with these molecular markers.
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Purpose: Age-related changes in articular cartilage are likely to
play a role in the aetiology of osteoarthritis (OA). One of the major
age-related changes in cartilage is the accumulation of advanced
glycation endproducts (AGEs). Pentosidine is considered to be an
adequate marker for the many AGEs formed in vivo. The best way
to study the effect of pentosidine on the development of OA is
by taking cartilage biopsies. However, this may interfere with the
disease process. Therefore, other sources need to be found to
overcome this problem. Skin and urine pentosidine may be used
as surrogate marker for cartilage pentosidine. The present study
describes the presence of AGE in skin and urine in relation to
OA severity, in a cohort of patients with very early signs of knee
and/or hip OA (CHECK).
Methods: Paired skin and cartilage samples were obtained post-
mortem (n=17). Furthermore, paired skin and urine samples were
obtained from a cohort of 300 patients with knee and/or hip pain
being part of the Dutch CHECK cohort. Since urine pentosidine
levels can vary in time due to diet variation, urine was collected
at 2 different time points with 3 month time interval. Levels of
pentosidine as AGE marker were measured in digested skin
samples and urine by HPLC. X-rays of both knees (weight bearing,
semi ﬂexed) and hips (weight bearing, AP) were made of all
patients and scored according to Kellgren and Lawrence (K&L).
Results: Cartilage pentosidine correlates well with skin pento-
sidine (R=0.473, p≤0.001). Of 205 patients all data could be
collected. The number of patients with a K&L grade 0 to 8 of the
sum of the 4 joints was 67, 57, 34, 15, 21, 3, 4, 2, and 2. Skin
pentosidine was higher in mild (total KL ≥ 4) compared to low
(total KL ≤ 3) radiographic OA (p<0.05). A marginal but statisti-
cal signiﬁcant correlation of skin pentosidine levels with the sum
K&L score was found. Separating hips and knees, the pentosidine
relation with severity of radiographic OA was found for the knee
but not for the hip. Skin and urine pentosidine levels correlate
marginal (R=0.285, p≤0.05). For urine pentosidine, no difference
could be found between mild and low radiographic OA, even not
when separating hips and knees. Age, creatinine clearance, gen-
